Ervilha Pereira, Pedro
Schuermans, Nika
Meylemans, Antoon
LeBlanc, Pontus
Versluys, Lauren
Copley, Katie E.
Rubien, Jack D.
Altheimer, Christopher
Peetermans, Myra
Debackere, Elke
Vanakker, Olivier
Janssens, Sandra
Baets, Jonathan
Verhoeven, Kristof
Lammens, Martin
Symoens, Sofie
De Paepe, Boel
Barmada, Sami J.
Shorter, James
De Bleecker, Jan L.
Bogaert, Elke
Dermaut, Bart http://orcid.org/0000-0002-6968-0572
Funding for this research was provided by:
Ghent University Fund for Alzheimer's disease and related disorders
Research Foundation Flanders (3G0H8318)
Association Belge contre les Maladies Neuro-Musculaires
Bijzonder Onderzoeksfonds UGent (01N10319)
Horizon 2020 Framework Programme (779257)
Research Foundation Flanders (1805021N)
NIH (T32GM132039, F31NS129101, R01GM099836, R01NS097542, R01NS113943, P30AG072931)
Robert Packard Center for ALS Research, Johns Hopkins University
Target ALS
Association for Frontotemporal Degeneration
ALS Association
Office of the Assistant Secretary of Defense for Health Affairs through the Amyotrophic Lateral Sclerosis Research Program (W81XWH-20-1-0242, W81XWH-17-1-0237)
family of Angela Dobson and Lyndon Welch
A. Alfred Taubman Medical Research Institute
Article History
Received: 29 December 2022
Revised: 15 March 2023
Accepted: 17 March 2023
First Online: 31 March 2023
Declarations
:
: J.S. is a consultant for Dewpoint Therapeutics, Confluence Therapeutics, ADRx, and Neumora. The other authors have nothing to declare.